Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

 

COVİD-19 Pnömonisi Gelişen Hastalarda Vitamin D Düzeylerinin Hastane Yatış Süresi ve Mortalite ile İlişkisinin Değerlendirilmesi: Retrospektif Analiz

Tanriverdi et al., International Journal of Tokat Medical Sciences, 17:18-25, Apr 2025
https://c19early.org/tanriverdi2.html
Mortality 60% Improvement Relative Risk Vitamin D for COVID-19  Tanriverdi et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 178 patients in Turkey (June 2020 - December 2022) Lower mortality with higher vitamin D levels (not stat. sig., p=0.071) c19early.org Tanriverdi et al., Int. J. Tokat Medic.., Apr 2025 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 126 studies, recognized in 18 countries.
No treatment is 100% effective. Protocols combine treatments.
5,800+ studies for 172 treatments. c19early.org
Retrospective 178 hospitalized COVID-19 pneumonia patients showing higher mortality with lower vitamin D levels.
This is the 217th of 219 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 221,958,417,113 vigintillion).
This study is excluded in the after exclusion results of meta analysis: unadjusted results with no group details.
risk of death, 59.6% lower, RR 0.40, p = 0.07, high D levels (≥30 ng/mL) 4 of 52 (7.7%), low D levels (<30 ng/mL) 24 of 126 (19.0%), NNT 8.8.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Tanriverdi et al., 30 Apr 2025, retrospective, Turkey, peer-reviewed, mean age 64.0, 1 author, study period 1 June, 2020 - 31 December, 2022. Contact: drfbhakante@gmail.com.
COVID-19 pnömonisi gelişen hastalarda vitamin D düzeylerinin hastane yatış süresi ve mortalite ile ilişkisinin değerlendirilmesi: Retrospektif bir çalışma
Hakan Tanrıverdi, Özel Echomar Hastanesi, Hastalıkları Göğüs, Öz
Amaç: COVID-19 pnömonisi nedeniyle yatarak tedavi gören hastalarda D vitamini düzeylerinin mortalite ve yatış süresi ile ilişkisinin değerlendirilmesi
References
Alessandri, Vitamin D and Lung Outcomes in Elderly COVID-19 Patients, Nutrients
Angelidi, Belanger, Lorinsky, Karamanis, Chamorro-Pareja et al., Vitamin D status is associated with in-hospital mortality and mechanical ventilation: A Cohort of COVID-19 Hospitalized Patients, Mayo Clin Proc
Annweiler, Hanotte, De L'eprevier, Sabatier, Lafaie et al., Vitamin D and survival in COVID-19 patients: A quasi-experimental study, J Steroid Biochem Mol Biol
Bianconi, Mannarino, Figorilli, Cosentini, Batori et al., Prevalence of vitamin D deficiency and its prognostic impact on patients hospitalized with COVID-19, Nutrition
Gedik, Sürücü, Covid-19 hastalarında serum 25-OH vitamin D3 düzeyleri ve hastalık aktivitesine etkileri: Prospektif kesitsel bir çalışma, Adıyaman Üniversitesi Sağlık Bilimleri Dergisi
Grant, Lahore, Mcdonnell, Baggerly, French et al., Evidence that Vitamin D supplementation could reduce risk of Influenza and COVID-19. Infections and Deaths, Nutrients
Haliloglu, Bilgili, Haliloglu, Yavuz, Cinel, Vitamin D level is associated with mortality predictors in ventilator-associated pneumonia caused by Acinetobacter baumannii, The Journal of Infection in Developing Countries
Hastie, Mackay, Ho, Celis-Morales, Katikireddi et al., Vitamin D COVID-19 pnömonisi gelişen hastalarda vitamin D düzeylerinin hastane yatış süresi ve mortalite ile ilişkisinin değerlendirilmesi: Retrospektif bir çalışma / Int J Tokat Med Sci concentrations and COVID-19 infection in UK Biobank, Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Hekimsoy, Dinç, Kafesçiler, Onur, Güvenç et al., Vitamin D status among adults in the Aegean region of Turkey, BMC Public Health
Karcıoğlu, Çöklü, Avrupa ülkelerinin D vitamini ortalama düzeyleri ile COVID-19 vaka ve mortalite oranları arasındaki ilişki, Anadolu Kliniği Tıp Bilimleri Dergisi
Kaynakça, None
Kumar, Karn, Trivedi, Kumar, Chauhan et al., Procalcitonin as a predictive marker in COVID-19: A systematic review and meta-analysis, PLoS One
Kumar, Rathi, Haq, Wimalawansa, Sharma, Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19, Virus Res
Li, Li, Wang, Treatment and prognosis of COVID-19: Current scenario and prospects (Review), Exp Ther Med
Liu, Sun, Wang, Zhang, Zhao et al., Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis, International Journal of Infectious Diseases
Mardani, Alamdary, Nasab, Gholami, Ahmadi et al., Association of vitamin D with the modulation of the disease severity in COVID-19, Virus Res
Meltzer, Best, Zhang, Vokes, Arora et al., Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results, JAMA Netw Open
Miroliaee, Salamzadeh, Shokouhi, Fatemi, Ardehali et al., Effect of vitamin D supplementation on procalcitonin as prognostic biomarker in patients with ventilator associated pneumonia complicated with vitamin D deficiency, Iran J Pharm Res
Osteoporoz Ve, Metabolik, Hastalıkları, Grubu, Türkiye Endokrinoloji Ve et al., Osteoporoz ve metabolik kemik hastalıkları tanı ve tedavi tanı ve tedavi kılavuzu
Pereira, Damascena, Azevedo, De Almeida Oliveira, Da et al., Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis, Crit Rev Food Sci Nutr
Singh, Rastogi, Puri, Ganesh, Naik et al., Therapeutic high-dose vitamin D for vitamin Ddeficient severe COVID-19 disease: randomized, double-blind, placebo-controlled study (SHADE-S), J Public Health
Sooriyaarachchi, Jeyakumar, King, Jayawardena, Impact of vitamin D deficiency on COVID-19, Clin Nutr ESPEN
Subramanian, Griffin, Hewison, Hopkin, Kenny et al., Vitamin D and COVID-19-Revisited, J Intern Med
Sulli, Gotelli, Casabella, Paolino, Pizzorni, COVID-19 pnömonisi gelişen hastalarda vitamin D düzeylerinin hastane yatış süresi ve mortalite ile ilişkisinin değerlendirilmesi: Retrospektif bir çalışma, Int J Tokat Med Sci
Tan, Ho, Kalimuddin, Cherng, Teh et al., Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus, COVID
Tuncer, Vitamin D ve COVID-19 Enfeksiyonu, Kocatepe Tıp Dergisi
Uçar, Taşlıpınar, Soydaş, Özcan, 25-OH Vitamin D Levels in Patients Admitted to Ankara Etlik Ihtisas Training and Research Hospital, European Journal of Basic Medical Sciences
Weir, Thenappan, Bhargava, Chen, Does vitamin D deficiency increase the severity of COVID-19?, Clinical Medicine
Yisak, Ewunetei, Kefale, Mamuye, Teshome et al., Effects of Vitamin D on COVID-19 Infection and Prognosis: A Systematic Review, Risk Manag Healthc Policy
Özmen, Çetin, D Vitamini ve COVID-19, İstanbul Rumeli Üniversitesi Sağlık Bilimleri Dergisi
Ünal, COVID-19 Tedavisinde Vitamin C ve D. SDÜ Tıp Fakültesi Dergisi
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit